Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 14, 369 - 370 (2008)
doi:10.1038/nm0408-369
Getting personal about treating HIV
James D Neaton1 & H Clifford Lane2
- James D. Neaton is in the Division of Biostatistics, School of Public Health, University of Minnesota, 2221 University Avenue Southeast, Room 200, Minneapolis, Minnesota 55414, USA.
- H. Clifford Lane is at the US National Institutes of Health, Building 10, Room 4-1479, 9000 Rockville Pike, Bethesda, Maryland 20892, USA. e-mail: jim@ccbr.umn.edu
Abstract
Genetic variants have been identified that may predict the response to HIV treatment (pages 413–420).
Personalized medicine, in which therapy is based on patient-specific information, is a recent trend in medicine that has been heralded by the sequencing of the human genome. For example, the selection of antiretrovirals for the treatment of people with HIV is currently tailored to the patient based on the genotype of the virus.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990?1999Bone Marrow Transplantation Original Article
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1?infected individualsNature Medicine Article (01 Apr 2008)
An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycleOncogene Original Article
See all 5 matches for Research